Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zoleikha Goleij"'
Autor:
Mehrdad Moosazadeh Moghaddam, Elham Behzadi, Hamid Sedighian, Zoleikha Goleij, Reza Kachuei, Mohammad Heiat, Abbas Ali Imani Fooladi
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
Infectious diseases are among the factors that account for a significant proportion of disease-related deaths worldwide. The primary treatment approach to combat microbial infections is the use of antibiotics. However, the widespread use of these dru
Externí odkaz:
https://doaj.org/article/43bc75f017a046018c13988bbb312642
Autor:
Farajolah Maleki, Noorkhoda Sadeghifard, Hamideh Mahmoodzadeh Hosseini, Salar Bakhtiyari, Zoleikha Goleij, Elham Behzadi, Hamid Sedighian, Abbas Ali Imani Fooladi
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 110, Iss , Pp 190-196 (2019)
Background: TGFαL3-SEB chimeric protein is a synthetic protein, which is produced by combining the third loop (L3) of transforming growth factor-α (TGF-α) with staphylococcal enterotoxin type B. To the best of our knowledge, anti-cancer activity o
Externí odkaz:
https://doaj.org/article/8be52acba7b34e0b9920b49387bab011
Autor:
Hamideh Mahmoodzadeh Hosseini, Mohsen Amin, Raheleh Halabian, Abbas Ali Imani Fooladi, Zoleikha Goleij
Publikováno v:
Toxin Reviews. :1-15
Bacterial toxins play major roles in developing infections and can cause diverse morphological and physiological changes via certain biochemical mechanisms leading to cell death. Most of the bacterial toxins induce apoptosis in host cell by intrinsic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6abbb1eef46749e6b1627cf001fea5a
https://doi.org/10.1080/15569543.2017.1294180
https://doi.org/10.1080/15569543.2017.1294180
Autor:
Rahim Sorouri, Abbas Ali Imani Fooladi, Raheleh Halabian, Hamid Sedighian, Zoleikha Goleij, Elham Behzadi, Hamideh Mahmoodzadeh Hosseini
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 200
Target-specific transport of therapeutic agents holds promise to increase the efficacy of cancer treatment by decreasing injury to normal tissues and post treatment problems. HER2 is a tumor cell surface marker that is expressed in 25-30 % of breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b27ee2529a83f8ef252f087360b153
https://pubmed.ncbi.nlm.nih.gov/32147458
https://pubmed.ncbi.nlm.nih.gov/32147458
Autor:
Jafar Amani, Hamideh Mahmoodzadeh Hosseini, Elham Behzadi, Mohsen Amin, Zoleikha Goleij, Abbas Ali Imani Fooladi
Publikováno v:
International Journal of Cancer Management.
Background: Despite major advances in cancer research, breast cancer still remains the most common cancer in women. Breast cancer is a heterogeneous disease, including at least 5 subtypes. Overexpression of human epidermal growth factor receptor 2 (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac02d210c17e4c1d335246a1fa0b0856
https://doi.org/10.5812/ijcm.83315
https://doi.org/10.5812/ijcm.83315
Autor:
Noorkhoda Sadeghifard, Farajolah Maleki, Zoleikha Goleij, Elham Behzadi, Hamideh Mahmoodzadeh Hosseini, Hamid Sedighian, Abbas Ali Imani Fooladi, Salar Bakhtiyari
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 110, Iss, Pp 190-196 (2019)
Background: TGFαL3-SEB chimeric protein is a synthetic protein, which is produced by combining the third loop (L3) of transforming growth factor-α (TGF-α) with staphylococcal enterotoxin type B. To the best of our knowledge, anti-cancer activity o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f66622224021da2fc4d1a255eec71e2
https://pubmed.ncbi.nlm.nih.gov/30471512
https://pubmed.ncbi.nlm.nih.gov/30471512